Leucker, T. M., Gerstenblith, G., Schär, M., Brown, T. T., Jones, S. R., Afework, Y., . . . Hays, A. G. (2020). Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia. J Am Heart Assoc.
Citação norma ChicagoLeucker, Thorsten M., Gary Gerstenblith, Michael Schär, Todd T. Brown, Steven R. Jones, Yohannes Afework, Robert G. Weiss, and Allison G. Hays. "Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia." J Am Heart Assoc 2020.
Citação norma MLALeucker, Thorsten M., et al. "Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia." J Am Heart Assoc 2020.